(WAND) – The Food and Drug Administration has recalled additional drugs used to treat high blood pressure.
According to the FDA some batches of Losartan potassium tablets are recalled. The drug is used to treat hypertension, patients with left ventricular hypertrophy and nephropathy in patients with type 2 diabetes.
Several batches of the drug have found N-methylnitrosobutyricacid (NMBA), which can potentially cause cancer.
The extension was extended to include an additional 3 lots of Losartan Potassium USP tablets and 2 lots of Losartan Potassium / Hydrochlorothiazide tablets, USP.
According to the FDA, Patients Taking Losartan Potassium USP Tablets and Losartan Potassium / Hydrochlorothiazide Tablets, USP should continue to take their medicines because the risk of harm to the patient's health may be greater if treatment is discontinued immediately , with no other alternative treatment. Patients should contact their pharmacist or physician, who may advise them on alternative treatment before returning their medication.
The products included in the withdrawal are listed below:
- 13668-115-90 Losartan potassium tablets, USP 100mg, 90 pieces 4DU3E009 31/2020
- 13668-115-10 Losartan Kali tablets, USP 100mg, 1000 pieces 4DU3D018 02/28/2021
- 13668-116-90 Losartan potassium / hydrochlorothiazide tablets, USP 50mg / 12.5mg, 90 units BEF7D051 11/30/2020
- 13668-118-90 Losartan potassium / hydrochlorothiazide tablets, USP 100mg / 25mg / 25 mg units. 4P04D007 07/07/2020